Stay updated on Zimura for AMD: Phase 3 Clinical Trial
Sign up to get notified when there's something new on the Zimura for AMD: Phase 3 Clinical Trial page.

Latest updates to the Zimura for AMD: Phase 3 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe publication entry for the two-year GATHER2 results has been updated from an online-ahead-of-print record to a final Ophthalmology 2026 April issue citation with volume/issue/page numbers. The page also reflects a new site revision version string.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Padova, Italy, 35128 and removed Padua, Italy, 35128 from the Locations list.SummaryDifference0.0%

- Check48 days agoChange DetectedAddition of Revision: v3.5.0 and removal of Revision: v3.4.3.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check77 days agoChange DetectedA new bibliographic entry was added to Publications: Khanani et al. Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial. The prior entry with slightly different capitalization and wording (2-year efficacy and safety results from the GATHER2 phase 3 trial) was removed.SummaryDifference0.0%

- Check84 days agoChange DetectedThis change reflects minor version updates: addition of Revision: v3.4.2 and removal of Revision: v3.4.1, with no changes to study details, eligibility, outcomes, or visible page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Zimura for AMD: Phase 3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zimura for AMD: Phase 3 Clinical Trial page.